Microparticle mediated thrombin generation in coronary artery disease

被引：0
|
作者：
Koganti, S. [1 ]
Eleftheriou, D. [2 ]
Kotecha, T. [1 ]
Brogan, P. [2 ]
Rakhit, R. [1 ]
机构：
[1] Royal Free Hosp, Cardiol, London, England
[2] Great Ormond St Hosp Sick Children, London, England
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6545
引用
收藏
页码：1379 / 1379
页数：1
相关论文
共 50 条
  • [41] Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease The Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease Trial
    Wiviott, Stephen D.
    Flather, Marcus D.
    O'Donoghue, Michelle L.
    Goto, Shinya
    Fitzgerald, Desmond J.
    Cura, Fernando
    Aylward, Philip
    Guetta, Victor
    Dudek, Dariusz
    Contant, Charles F.
    Angiolillo, Dominick J.
    Bhatt, Deepak L.
    CIRCULATION, 2011, 123 (17) : 1854 - +
  • [42] Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport
    Finn, Nnenna A.
    Eapen, Danny
    Manocha, Pankaj
    Al Kassem, Hatem
    Lassegue, Bernard
    Ghasemzadeh, Nima
    Quyyumi, Arshed
    Searles, Charles D.
    FEBS LETTERS, 2013, 587 (21) : 3456 - 3463
  • [43] Evaluation of indirect microparticle activity and parameters of thrombin generation test in healthy infants
    Orhon, Filiz Simsek
    Egin, Yonca
    Ulukol, Betul
    Baskan, Sevgi
    Akar, Nejat
    THROMBOSIS RESEARCH, 2014, 133 (02) : 281 - 284
  • [44] Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting
    Nakahira, Atsushi
    Sasaki, Yasuyuki
    Hirai, Hidekazu
    Fukui, Toshihiro
    Matsuo, Mitsunori
    Takahashi, Yosuke
    Kotani, Shinsuke
    Suehiro, Shigefumi
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2010, 10 (04) : 555 - 560
  • [45] Cell activation and thrombin generation in shed mediastinal blood after coronary artery bypass grafting
    Johnell, M
    Larsson, R
    Larsson, A
    Thelin, S
    Siegbahn, A
    THROMBOSIS AND HAEMOSTASIS, 1999, : 632 - 633
  • [46] Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease
    Oldgren, J
    Siegbahn, A
    Grip, L
    Linder, R
    Thygesen, K
    Wallentin, L
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) : 381 - 387
  • [47] Thrombin receptor antagonists may become an important antiplatelet therapy for coronary artery disease
    Van de Werf, Frans
    EUROPEAN HEART JOURNAL, 2010, 31 (21) : 2575 - 2576
  • [48] Association Between Flow Mediated Vasodilation and Coronary Artery Disease
    Shekar, Chandana
    Li, Dong
    Cherukuri, Lavanya
    Shaikh, Kashif
    Hamal, Sajad
    Birudaraju, Divya
    Shodhan, Shivani
    Nezarat, Negin
    Dailing, Christopher
    Flores, Ferdinand
    Roy, Sion
    Budoff, Matthew
    CIRCULATION, 2018, 138
  • [49] Risk of coronary artery disease associated with thrombin activable fibrinolysis inhibitor (TAFI) levels
    Santamaria, A
    Martinez, A
    Oliver, A
    Tirado, I
    Borrell, M
    Mateo, J
    Souto, JC
    Fontcuberta, J
    EUROPEAN HEART JOURNAL, 2002, 23 : 566 - 566
  • [50] CORONARY-ARTERY DISEASE INCREASED WHEN SERUM ANTI-THROMBIN DECREASED
    MOLK, B
    HAMSTRA, R
    ENS, G
    HAMSTRA, S
    CLINICAL RESEARCH, 1981, 29 (01): : A16 - A16
12345